Sy Jennifer 4
4 · AEON Biopharma, Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
Sy Jennifer
PRINCIPAL ACCOUNTING OFFICER
Transactions
- Award
Class A Common Stock
[F1]2026-02-17+575,000→ 575,251 total - Award
Class A Common Stock
[F2]2026-03-04+925,925→ 1,501,176 total
Footnotes (2)
- [F1]Represents an award of restricted stock units granted on February 17, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date.
- [F2]Represents outstanding cash-settled restricted stock units granted on May 21, 2025 (the "Grant Date") that were modified on March 4, 2026 to be settled in stock instead of cash upon vesting. The restricted stock units continue to vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. The restricted stock units were originally reported in Table II on a Form 4 filed on May 23, 2025.
Signature
/s/ Alexander Wilson, as Attorney-in-Fact, for Jennifer Sy|2026-03-05